QUARTUCCIO, NATALE
 Distribuzione geografica
Continente #
EU - Europa 6.146
NA - Nord America 1.266
AS - Asia 812
SA - Sud America 316
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 2
Totale 8.610
Nazione #
IT - Italia 4.179
US - Stati Uniti d'America 1.228
RU - Federazione Russa 978
NL - Olanda 293
SG - Singapore 273
BR - Brasile 251
IE - Irlanda 214
CN - Cina 196
SE - Svezia 178
HK - Hong Kong 92
DE - Germania 79
VN - Vietnam 76
IN - India 55
GB - Regno Unito 51
FR - Francia 44
FI - Finlandia 43
CA - Canada 23
BD - Bangladesh 19
IQ - Iraq 18
AR - Argentina 17
TN - Tunisia 15
PL - Polonia 13
TR - Turchia 12
CH - Svizzera 11
CO - Colombia 11
CZ - Repubblica Ceca 11
IR - Iran 9
CL - Cile 8
EC - Ecuador 7
ES - Italia 7
ID - Indonesia 7
LT - Lituania 7
MX - Messico 7
UZ - Uzbekistan 7
ZA - Sudafrica 7
AT - Austria 6
AZ - Azerbaigian 6
JP - Giappone 6
MA - Marocco 6
PY - Paraguay 6
SA - Arabia Saudita 6
UA - Ucraina 6
AL - Albania 5
BE - Belgio 5
PE - Perù 5
PH - Filippine 5
PK - Pakistan 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
CI - Costa d'Avorio 3
JM - Giamaica 3
KE - Kenya 3
KG - Kirghizistan 3
NO - Norvegia 3
RO - Romania 3
VE - Venezuela 3
AU - Australia 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
EU - Europa 2
IL - Israele 2
KZ - Kazakistan 2
PT - Portogallo 2
SN - Senegal 2
AO - Angola 1
BN - Brunei Darussalam 1
BW - Botswana 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
HU - Ungheria 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
MM - Myanmar 1
NP - Nepal 1
PA - Panama 1
PR - Porto Rico 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.585
Città #
Milan 414
Rome 354
Moscow 294
Dublin 213
Ashburn 181
Naples 176
Singapore 154
Nyköping 135
Dallas 122
Chandler 116
San Jose 101
Turin 92
Hong Kong 91
Bari 75
Bologna 72
Beijing 71
Palermo 70
Florence 58
Genoa 48
Catania 44
Council Bluffs 40
Munich 40
The Dalles 38
Los Angeles 34
Dong Ket 32
Dearborn 30
Princeton 29
Medford 28
Messina 27
Jacksonville 26
Trieste 26
Modena 25
Brescia 24
Cagliari 24
New York 23
Lauterbourg 22
Pisa 22
São Paulo 22
Parma 21
Hyderabad 20
Verona 20
Lancaster 19
Pune 19
Cambridge 18
Bergamo 17
Des Moines 17
Padova 17
Turku 15
Cascina 14
Reggio Emilia 14
Buffalo 13
Monza 13
Novara 12
Pescara 12
Prato 12
Santa Clara 12
Ben Arous 11
Padua 11
Jinan 10
Modugno 10
Perugia 10
Udine 10
Venice 10
Bremen 9
Civitanova Marche 9
Ho Chi Minh City 9
Lucca 9
Montreal 9
San Mateo 9
Sassari 9
Taranto 9
Ancona 8
Cosenza 8
Denver 8
Hanoi 8
Helsinki 8
London 8
Redondo Beach 8
Atlanta 7
Brooklyn 7
Livorno 7
Nanchang 7
Nanjing 7
Orem 7
Oristano 7
Ravenna 7
Shenyang 7
Treviglio 7
Vicenza 7
Warsaw 7
Aversa 6
Capaccio 6
Caserta 6
Casoria 6
Cepagatti 6
Ferrara 6
Fisciano 6
Gragnano 6
Meda 6
Nuremberg 6
Totale 4.022
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 4.705
111In-Pentetreotide for treatment of neuroendocrine tumours: an alternative therapeutic option in particular cases 243
2 years-survival analysis of patients with non-small cell lung cancer by means of 2deoxy-2-[18F]fluoro-D-glucose positron emission tomography: implications of maximum standardized uptake value (SUVmax) 201
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 184
Prognostic and diagnostic value of [18F]FDG-PET/CT in restaging patients with small cell lung carcinoma: an Italian multicenter study 178
A microdosimetric model of solid tumour microvasculature for radiopharmaceuticals labeled with 223 Ra, 111 In, 131 I and 177 Lu 175
ASSOCIATION OF PRIMARY HYPERPARATHYROIDISM (P-HYPERPTH) WITH NODULAR TOXIC GOITER (NTG): A PROSPECTIVE STUDY AT AN OUTPATIENT OSTEOPOROSIS SERVICE 159
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low-risk differentiated thyroid cancer? 157
Unconventional non-amino acidic PET radiotracers for molecular imaging in gliomas 151
Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer? 148
Technetium-99m (99mTc)-labelled sulesomab in the management of malignant external otitis: is there any role? 146
Pediatric bone sarcoma: Diagnostic performance of 18 F-FDG PET/CT versus conventional imaging for initial staging and follow-up 146
Italian Multicenter Study on Accuracy of18F-FDG PET/CT in Assessing Bone Marrow Involvement in Pediatric Hodgkin Lymphoma 146
High grade gliomas associated with abscess: description of two rare cases and role of 99mTc-Leukoscan 142
Correction to: 18F-FMISO PET imaging: insights over MRI in patients with glioma (Clinical and Translational Imaging, (2020), 8, 1, (3-10), 10.1007/s40336-019-00353-0) 138
The additional value of 18F-FDG PET and MRI in patients with glioma: A review of the literature from 2015 to 2020 134
Initial results of the use of a novel semiquantitative parameter in three-phase bone scan to predict 99mTc-HMPAO-labeled leukocyte scintigraphy in patients with unilateral total knee replacement 128
Prediction of 2 years-survival in patients with stage I and II non-small cell lung cancer utilizing F-18-FDG PET/CT SUV quantification 127
Paediatric bone sarcoma: FDG-PET/CT vs. conventional imaging. A collaborative study 119
The Role of 2deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography and Maximum Standardized Uptake Value in Predicting Prognosis of patients Wihth Non-Small Cell Lug Cancer in Different Stages (I-IV) 118
Emerging applications of imaging in glioma: focus on PET/MRI and radiomics 117
Is pre-treatment SUVmax an useful indicator of survival in patients with advanced non-small-cell lung cancer? 117
[18F] Fluorothymidine Positron Emission Tomography Imaging in Primary Brain Tumours: A Systematic Review 108
Two-year survival prediction in patients with stage I and II non-small cell lung cancer utilizing 18F-FDG PET/CT SUV quantification 102
Stage III-IV non small cell lung cancer: the impact of SUVmax and %SUVmax in predicting survival after chemotherapy 96
A Multimodal Clinical Approach for the Treatment of Bone Metastases in Solid Tumors 93
RADIOIODINE UPTAKE IN ABDOMINAL DERMOID CYST IN A PATIENT WITH DIFFERENTIATED THYROID CANCER (DTC) 83
State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation 81
Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review 65
The role of PET radiomic features in prostate cancer: a systematic review 56
The Role of Theragnostics in Breast Cancer: A Systematic Review of the Last 12 Years 47
Totale 8.610
Categoria #
all - tutte 18.388
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.388


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022151 0 18 0 6 22 1 6 7 1 10 17 63
2022/2023599 42 87 31 32 24 52 26 17 246 15 19 8
2023/20241.308 19 40 70 64 67 106 101 121 96 203 178 243
2024/20253.148 212 141 232 316 264 193 239 461 406 226 220 238
2025/20262.961 207 187 199 231 232 565 293 330 394 195 66 62
2026/2027137 63 74 0 0 0 0 0 0 0 0 0 0
Totale 8.610